文献速递母胎医学产科

宫内胎儿镜激光手术与期待治疗在1期双胎输血综合征中的国际随机试验

Intrauterine fetoscopic laser surgery versus expectant management in stage 1 twin-to-twin transfusion syndrome: an international randomized trial.
PubMed 文献 · Am J Obstet Gynecol · 2020-11-26

这项多中心随机试验纳入16–26周、无症状、宫颈>15 mm的1期双胎输血综合征孕妇,比较立即激光手术与期待治疗。因入组缓慢在117例时提前终止,两组6个月无严重神经病学并发症存活率无显著差异(77% vs 78%,P=.88),期待治疗组约41%保持稳定,但约60%进展需转诊手术。

要点

  • 1期无症状且宫颈>15 mm者,立即激光与期待治疗的6个月无严重神经病学并发症存活率无差异。
  • 期待治疗组约41%保持稳定,但约60%会进展,需快速转至手术中心。
  • 该试验因入组缓慢提前终止,证据强度受限。

核心结论

  • 对于无症状、宫颈长度>15 mm的1期双胎输血综合征孕妇,早期胎儿手术不太可能获益。
  • 期待治疗对这些病例是合理的,但约60%的病例会进展并需要快速转至手术中心。

研究设计与样本

  • 多中心随机试验,2011至2018年招募,产后随访6个月,在欧洲和美国的9个胎儿医学中心开展。
  • 纳入16–26周、无症状、宫颈>15 mm且能在诊断后48小时内到达手术中心的1期双胎输血综合征孕妇,随机分配至期待治疗或立即手术。
  • 立即手术组在72小时内行经皮激光凝固吻合血管;期待治疗组计划每周超声随访,若病情恶化(进展至更高Quintero分期或羊水过多母体并发症)则提供补救性胎儿镜凝固术。
  • 主要结局为6个月时无严重神经病学并发症的存活;次要结局包括严重早产并发症和母体并发症。
  • 计划入组200例,因7年入组缓慢在117例时终止:期待治疗组58例,立即激光组59例。

主要发现

  • 无严重神经病学并发症存活:期待治疗组84/109(77%),立即手术组89/114(78%),P=.88。
  • 严重神经病学并发症:期待治疗组5/109(4.6%),立即手术组3/114(2.6%),P=.49。
  • 期待治疗组中24/58(41%)病例保持稳定,其中36/44(86%)在6个月时双胎均无严重并发症存活。
  • 手术后无严重神经病学并发症存活率低于非进展病例,但差异无统计学意义(立即手术78%,补救手术71%)。

临床怎么用

  • 对于无症状、宫颈>15 mm的1期双胎输血综合征孕妇,可选择期待治疗而非立即激光手术。
  • 期待治疗期间需每周超声随访,并确保若进展至更高Quintero分期或出现羊水过多母体并发症时能快速转至手术中心行补救性激光。

局限性

  • 试验因入组缓慢在117/200例时提前终止,统计效能受限。
  • 结果仅适用于无症状、宫颈>15 mm且能在48小时内到达手术中心的1期双胎输血综合征孕妇,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Selective fetoscopic laser coagulation of the intertwin anastomotic chorionic vessels is the first-line treatment for twin-twin transfusion syndrome. However, in stage 1 twin-twin transfusion syndrome, the risks of intrauterine surgery may be higher than those of the natural progression of the condition. OBJECTIVE: This study aimed to compare immediate surgery and expectant follow-up in stage 1 twin-twin transfusion syndrome. STUDY DESIGN: We conducted a multicentric randomized trial, which recruited from 2011 to 2018 with a 6-month postnatal follow-up. The study was conducted in 9 fetal medicine centers in Europe and the Unites States. Asymptomatic women with stage 1 twin-twin transfusion syndrome between 16 and 26 weeks' gestation, a cervix of >15 mm, and access to a surgical center within 48 hours of diagnosis were randomized between expectant management and immediate surgery. In patients allocated to immediate laser treatment, percutaneous laser coagulation of anastomotic vessels was performed within 72 hours. In patients allocated to expectant management, a weekly ultrasound follow-up was planned. Rescue fetoscopic coagulation of anastomoses was offered if the syndrome worsened as seen during a follow-up, either because of progression to a higher Quintero stage or because of the maternal complications of polyhydramnios. The primary outcome was survival at 6 months without severe neurologic morbidity. Severe complications of prematurity and maternal morbidity were secondary outcomes. RESULTS: The trial was stopped at 117 of 200 planned inclusions for slow accrual rate over 7 years: 58 women were allocated to expectant management and 59 to immediate laser treatment. Intact survival was seen in 84 of 109 (77%) expectant cases and in 89 of 114 (78%) (P=.88) immediate surgery cases, and severe neurologic morbidity occurred in 5 of 109 (4.6%) and 3 of 114 (2.6%) (P=.49) cases in the expectant and immediate surgery groups, respectively. In patients followed expectantly, 24 of 58 (41%) cases remained stable with dual intact survival in 36 of 44 (86%) cases at 6 months. Intact survival was lower following surgery than for the nonprogressive cases, although nonsignificantly (78% and 71% following immediate and rescue surgery, respectively). CONCLUSION: It is unlikely that early fetal surgery is of benefit for stage 1 twin-twin transfusion syndrome in asymptomatic pregnant women with a long cervix. Although expectant management is reasonable for these cases, 60% of the cases will progress and require rapid transfer to a surgical center.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Stirnemann J, Slaghekke F, Khalek N, et al. Intrauterine fetoscopic laser surgery versus expectant management in stage 1 twin-to-twin transfusion syndrome: an international randomized trial. Am J Obstet Gynecol. 2020. PMID: 33248135. doi:10.1016/j.ajog.2020.11.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。